232 related articles for article (PubMed ID: 34918367)
1. Impact of pharmacological interventions on anthropometric indices in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Jun; 96(6):758-780. PubMed ID: 34918367
[TBL] [Abstract][Full Text] [Related]
2. The Effect of Thiazolidinediones in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Adv Ther; 2024 Jun; 41(6):2168-2195. PubMed ID: 38683294
[TBL] [Abstract][Full Text] [Related]
3. Impact of pharmacological interventions on insulin resistance in women with polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Mar; 96(3):371-394. PubMed ID: 34713480
[TBL] [Abstract][Full Text] [Related]
4. Impact of pharmacological interventions on biochemical hyperandrogenemia in women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Arch Gynecol Obstet; 2023 May; 307(5):1347-1376. PubMed ID: 35434762
[TBL] [Abstract][Full Text] [Related]
5. Effect of pharmacological interventions on lipid profiles and C-reactive protein in polycystic ovary syndrome: A systematic review and meta-analysis.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Clin Endocrinol (Oxf); 2022 Apr; 96(4):443-459. PubMed ID: 34779013
[TBL] [Abstract][Full Text] [Related]
6. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
[TBL] [Abstract][Full Text] [Related]
7. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
8. Effects of different insulin sensitisers in the management of polycystic ovary syndrome: A systematic review and meta-analysis.
Melin JM; Forslund M; Alesi SJ; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena AS; Witchel SF; Mousa A; Teede HJ
Clin Endocrinol (Oxf); 2024 Feb; 100(2):149-163. PubMed ID: 37933831
[TBL] [Abstract][Full Text] [Related]
9. The impact of metformin with or without lifestyle modification versus placebo on polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials.
Melin J; Forslund M; Alesi S; Piltonen T; Romualdi D; Spritzer PM; Tay CT; Pena A; Witchel SF; Mousa A; Teede H
Eur J Endocrinol; 2023 Aug; 189(2):S37-S63. PubMed ID: 37536294
[TBL] [Abstract][Full Text] [Related]
10. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
Lord JM; Flight IH; Norman RJ
Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of statins, metformin, spironolactone and combined oral contraceptives in reducing testosterone levels in women with polycystic ovary syndrome: a network meta-analysis of randomized clinical trials.
Almalki HH; Alshibani TM; Alhifany AA; Almohammed OA
BMC Womens Health; 2020 Apr; 20(1):68. PubMed ID: 32248801
[TBL] [Abstract][Full Text] [Related]
12. Effects of acarbose on polycystic ovary syndrome: a meta-analysis.
Zhang YY; Hou LQ; Zhao TY
Exp Clin Endocrinol Diabetes; 2014 Jun; 122(6):373-8. PubMed ID: 24941435
[TBL] [Abstract][Full Text] [Related]
13. A systematic review and meta-analysis of randomized controlled trials comparing pioglitazone versus metformin in the treatment of polycystic ovary syndrome.
Du Q; Wang YJ; Yang S; Wu B; Han P; Zhao YY
Curr Med Res Opin; 2012 May; 28(5):723-30. PubMed ID: 22462531
[TBL] [Abstract][Full Text] [Related]
14. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
[TBL] [Abstract][Full Text] [Related]
15. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
[TBL] [Abstract][Full Text] [Related]
16. Does metformin improve reproduction outcomes for non-obese, infertile women with polycystic ovary syndrome? Meta-analysis and systematic review.
Magzoub R; Kheirelseid EAH; Perks C; Lewis S
Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():38-62. PubMed ID: 35149444
[TBL] [Abstract][Full Text] [Related]
17. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
[TBL] [Abstract][Full Text] [Related]
18. Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
Goldberg A; Graca S; Liu J; Rao V; Witchel SF; Pena A; Li R; Mousa A; Tay CT; Pattuwage L; Teede H; Yildiz BO; Ee C
Obes Rev; 2024 May; 25(5):e13704. PubMed ID: 38355887
[TBL] [Abstract][Full Text] [Related]
19. Impact of metformin on the clinical and metabolic parameters of women with polycystic ovary syndrome: a systematic review and meta-analysis of randomised controlled trials.
Abdalla MA; Shah N; Deshmukh H; Sahebkar A; Östlundh L; Al-Rifai RH; Atkin SL; Sathyapalan T
Ther Adv Endocrinol Metab; 2022; 13():20420188221127142. PubMed ID: 36225721
[TBL] [Abstract][Full Text] [Related]
20. Drug interventions for the treatment of obesity in children and adolescents.
Mead E; Atkinson G; Richter B; Metzendorf MI; Baur L; Finer N; Corpeleijn E; O'Malley C; Ells LJ
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012436. PubMed ID: 27899001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
